Guangdong Kanghua Healthcare Co Ltd
HKEX:3689
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/FCFF
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.
Valuation Scenarios
If EV/FCFF returns to its 3-Year Average (1.8), the stock would be worth HK$6.8 (237% upside from current price).
| Scenario | EV/FCFF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.5 | HK$2.02 |
0%
|
| 3-Year Average | 1.8 | HK$6.8 |
+237%
|
| 5-Year Average | 2.7 | HK$10.26 |
+408%
|
| Industry Average | 28.7 | HK$107.8 |
+5 237%
|
| Country Average | 28.8 | HK$108.01 |
+5 247%
|
Forward EV/FCFF
Today’s price vs future free cash flow to firm
Peer Comparison
| Market Cap | EV/FCFF | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
G
|
Guangdong Kanghua Healthcare Co Ltd
HKEX:3689
|
675.5m HKD | 0.5 | 5.9 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
96.6B USD | 17.2 | 14.4 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 250.4 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.2B ZAR | 40.4 | 13.8 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.8B MYR | 41.5 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.5B ZAR | 5.4 | 4.5 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.8B BRL | -33 | 17.9 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.4B USD | 10.2 | 11.2 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
103.3B CNY | 26.8 | 30.7 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 109.5 | 61.3 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.9B USD | 27.5 | 30.9 |
Market Distribution
| Min | 0 |
| 30th Percentile | 14.5 |
| Median | 28.8 |
| 70th Percentile | 57 |
| Max | 307 555.7 |
Other Multiples
Guangdong Kanghua Healthcare Co Ltd
Glance View
Guangdong Kanghua Healthcare Co., Ltd. engages in the provision of hospital and management services. The company is headquartered in Dongguan, Guangdong. The company went IPO on 2016-11-08. The firm operates in four segments. Hospital Services segment mainly operates in Kanghua Hospital, providing inpatient medical care, outpatient medical care and physical examination services. Rehabilitation and Other Healthcare Services segment mainly provides rehabilitation services such as nursing care, training for the disabled, and other medical-related services for patients with physical and mental disabilities. Sales of Pharmaceutical products segment mainly sells pharmaceuticals and medical consumables to patients. Others segment is mainly engaged in elderly medical and healthcare services. The firm mainly operates two hospitals, namely Kanghua hospital and Renkang hospital.
